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Background: CMV is the most common cause of congenital infection in the whole world (0.2 to 2.2 %). That
infection may be symptomatic or asymptomatic at birth and, although asymptomatic cases at birth are more
common, some children may develop late sequelae, and require medical intervention. This study aimed to
determine the prevalence of CMV congenital infections in children who were born in a public hospital in Ilhéus,
Brazil, and to evaluate the clinical progression in infected newborns.
Methods: CMV congenital infection was determined by detecting viral DNA through nested PCR.
Results: The viral DNA was detected in 25 newborns, showing a prevalence of 1.19 % (25/2100) of CMV congenital
infection. In regards to the risk factors from mothers, only the variables: age of mothers (p = 0.003), number of
children (p = 0.011), and use of medications (p < 0.001) were associated with the congenital infection.
Approximately 12 % of children presented symptoms. One death and two auditory alterations were detected
during the monitored period. Only 50 % of children diagnosed attended their medical follow.
Conclusions: The prevalence found confirms the findings from other studies which involved other poor
populations. Two children presented impaired hearing during the monitored period; that was one of the main
sequelae from the infection. It is noteworthy that there was low adherence to medical follow-up which may
underestimate data on complications of the infection CMV. Late symptoms can be mistaken for other diseases or
even go unnoticed.
Keywords: Congenital cytomegalovirus disease, Newborn screening, Epidemiology, Late sequelae, Medical
supervision
Abbreviations: BERA, Brainstem-evoked response audiometry; CMV, Cytomegalovirus; GOT, Glutamic oxaloacetic
transaminase; UESC, Universidade Estadual de Santa CruzBackground
Cytomegalovirus (CMV) infection is common worldwide
and its prevalence is inversely proportional to the socio-
economic status of the population and can be higher
than 90 % in developing countries including Brazil [1].
In addition, CMV infection has been associated with
ethnicity and contact with CMV sources, including
people who work in daycare facilities [2, 3].* Correspondence: ljmarin@uesc.br
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tion worldwide and its prevalence varies between 0.2 %
and 2.2 % of all infants born [4, 5]. It may be symptom-
atic, but in 85 – 90 % of the cases, it is asymptomatic at
birth. Approximately 90 % of the symptomatic cases in-
volve neurological impairment and unilateral or bilateral
sensorineural deafness, with a significant impact on the
quality of life, and these cases may progress to death [6, 7].
However, 5 – 15 % of asymptomatic children can present
late symptoms and develop progressive, irreversible future
sequelae, including impairment of the central nervousle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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chomotor development, among other complications [8, 9].
The diagnosis of the congenital infection should be
done before the third week of life because, after this
period, it is not possible to assess whether viral trans-
mission occurred through the placenta or through ex-
ternal sources such as the birth canal, saliva, or
breast milk [10].
The early diagnosis of CMV congenital infection and
clinical follow-up are essential to detect and manage the
disease and prevent sequelae [9, 11]. Despite the import-
ance of this infection, many children who are congeni-
tally infected with CMV remain undetected because
diagnosis is not performed by the public health system
in many countries, including Brazil.
This study aimed to evaluate the prevalence of
CMV congenital infections in a public hospital in
Ilhéus, Brazil, and its clinical progression during the
first years of life.
Methods
A total of 2100 newborns were included in this study, at
any gestational age and in any clinical condition. These
newborns were born between February 2010 and De-
cember 2012 in Santa Helena Maternity, São José Hos-
pital, located in Ilhéus, southern Bahia, Brazil. Subjects
whose parents or guardians refused to sign the consent
form were excluded from the study. The study was ap-
proved by the Human Research Ethics Committee of the
Universidade Estadual de Santa Cruz (UESC) under
protocol No. 209/08.
Sampling
Saliva samples from the newborns were collected with
sterile swabs, which were gently placed in their mouth
for 1 min to moisten the swabs and transferred to sterile
plastic tubes containing 700 μL of transport medium
(MEM Earle, Cultilab). After 60 min, the swabs were dis-
carded and the medium was stored at 4 °C until further
processing. Urine samples were collected aseptically in
hypoallergenic collecting bags. Care was also taken to
avoid contamination with meconium. We chose to also
use the saliva that has been found to saliva samples
seems to be a good specimens for a neonatal screening
of congenital CMV due to its ease of collection and for
having sensitivity and specificity similar to urine, the
gold standard [12].
Nested PCR
The viral genome was detected via nested PCR in at
least two saliva and urine samples obtained before the
third week of life. These samples were subjected to
PCR without previous DNA extraction and were
heated for 6 min at 94 °C. A 2.5 μL-aliquot of salivaor 1.5 μL-aliquot of urine was added to the reaction
mixture containing the external primers MIE4-MIE5
[13], a buffer solution (50 mM of KCl and 20 mM of
Tris HCl, pH 8.5), 1.5 mM of MgCl2, 150 μM of each
deoxynucleoside triphosphate; 1U of Taq DNA poly-
merase (Invitrogen Life Technologies), and 0.3 μM of
each primer, adjusted to a final volume of 25 μL. The
mixture was subjected to an initial cycle at 94 °C for
2 min, 55 °C for 90 s, and 72 °C for 2 min, followed
by 34 cycles at 94 °C for 1 min, 55 °C for 90 s, and
72 °C for 2 min, and an additional extension cycle of
10 min at 72 °C. In the second PCR reaction with
the internal primers IE1-IE2, a 0.5 μL-aliquot of
each amplified product was used [14]. The reaction
mixtures containing the same reagents cited above
were subjected to 30 cycles at 94 °C for 1 min, 55 °
C for 1 min, and 72 °C for 1 min, followed by an
additional extension cycle of 3 min at 72 °C. Positive
and negative controls were used. All samples con-
taining viral DNA were retested at least twice using
two pairs of primers to confirm the results. The pri-
mer pairs used and the size of the amplified frag-
ments are shown in Table 1.
To visualize the PCR products, 10 μL of each amplified
product was added to 1.0 μL of GelRed dye and subjected
to agarose gel electrophoresis at 2 %. The electrophoresis
was conducted at 150 V for 30 min using a Tris/Borate/
EDTA buffer solution (0.089 M of Tris, 0.089 M of borate,
0.01 M of EDTA, pH 7.5). Gels were photographed using
a digital camera coupled with a UV transilluminator.
Medical supervision
All children with CMV congenital infections who
attended follow-up visits (conducted every three
months) were evaluated as follows:
a) Clinical examinations, including measurement of
weight, height, head and chest circumference, liver
size, spleen size, and fundoscopy.
b) Complementary examinations: hemogram (including
platelet count), liver function test, and measurement
of total and fraction bilirubin.
c) Hearing assessment.
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To correlate maternal risk factors with the prevalence of
CMV infection, the following maternal variables were
collected through the application of a questionnaire: age,
ethnicity, marital status, number of children, schooling,
and use of legal and illegal drugs.
The prevalence of positive cases and symptoms was
determined by calculating the prevalence rate.
The epidemiological data and the clinical manifestations
in infected and uninfected children were compared. SPSS
software version 20.0 was used for statistical analysis. The
chi-squared test with Yates’ correction was used whenever
applicable. The Kolmogorov-Smirnov test was conducted
to assess the normality of quantitative data. P-values lower
than 0.05 were considered statistically significant.
Results
Urine and/or saliva samples were collected from 2100
children. Viral DNA was detected in 25 newborns, yield-
ing a prevalence rate of CMV congenital infection of
1.19 % in Ilhéus. The amplified product of 159 bp corre-
sponding to the CMV DNA related to one positive case
is presented in Fig. 1.
Only one newborn was symptomatic at birth. How-
ever, among the 24 newborns who were clinically diag-
nosed as asymptomatic, 11 presented one or more
general clinical findings that could suggest the presence
of cytomegalovirus disease, as shown in Table 2. In order
to verify future symptoms in the asymptomatic group, it
was conducted a follow-up visits involving complete and
periodical clinical examinations of the newborns until
the second year of life. During this period, none of the
monitored children made use of antiviral drugs.
The child who presented symptoms at birth died on
the seventh day due to cytomegalovirus disease. This fe-
male infant was born by normal delivery in a 36-weekFig. 1 Agarose gel. Agarose gel at 2 % stained with GelRed dye, showing t
during screening for CMV congenital infection. Columns 1 and 10: 100-bp
column 7: positive sample (159-bp amplicon); columns 8–9: positive contropregnancy, weighed 2,095 g, had a head circumference
of 24 cm, chest circumference of 27.5, and body length
of 44 cm. The clinical changes during disease progres-
sion included discomfort while breathing, globular and
flaccid abdomen, generalized edema, jaundice, tachyp-
nea, petechiae, sloughing, and weak reflexes. The labora-
tory alterations included C-reactive protein levels of
48 mg/dL (reference value of 0.1 mg/dL), marked cell
atypia, serum glutamic oxaloacetic transaminase (GOT)
levels of 78 URF/mL (reference value of 4–36 URF/mL),
and thrombocytopenia.
Only 12 children (50 %) attended the periodic follow-
up visits. Of these, only 2 children (16.7 %) presented
late CMV symptoms (auditory alterations) and were re-
ferred to brainstem-evoked response audiometry
(BERA). However, both children needed to relocate and
were no longer monitored.
In relation to epidemiological characteristics of the
studied population according to CMV infection positiv-
ity, the age group of 12–15 years presented the highest
number of children with CMV congenital infection (p =
0.033). In addition, out of the 25 mothers of infected
newborns, 17 were primiparae (p = 0.011) (Table 3).
There was no statistically significant correlation between
the data on delivery and the characteristics at birth of
the infected newborns (Table 4).
Discussion
The prevalence of 1.19 % found in Ilhéus was similar to
the findings of other studies conducted in low-income
regions. In fact, the prevalence varied between 0.2 % and
2.2 % depending on the region and on the socioeco-
nomic status of the population [5, 7, 15–19].
With regard to the symptoms, 87.5 % of the newborns
were asymptomatic and 12.5 % showed symptoms. One
of them showed symptoms at birth and two of themhe nested PCR results using urine or saliva samples of 6 newborns
markers; column 2: negative control; columns 3–6: negative samples;
ls
Table 4 Data from deliveries and clinical characteristics of






Caesarean section 9 (36 %) 1056 (50.9 %) 0.335
Normal delivery 14 (56 %) 997 (48 %)
Normal weight at birth 20 (80 %) 1799 (86.7 %) 0.268
Low body weight 4 (16 %) 162 (7.8 %)
Premature 1 (4 %) 97 (4.7 %) 0.642
Term birth 22 (88 %) 849 (41 %)
Post-term birth 0 (0.0 %) 1 (0.05 %)
Normal head circumference 19 (76 %) 1252 (60.3 %) 0.423
Decreased head circumference
with deficiency
2 (8 %) 57 (2.7 %)
Increased head circumference 2 (8 %) 194 (9.3 %)
Values of p < 0.05 are considered significant
Table 2 Clinical findings suggesting congenital CMV at the
time of birth
General clinical aspects Number of children %
Low weight 6 25
Prematurity 2 8.3
Petechiae 1 4.17
Bacterial Conjunctivitis 1 4.17
Severe anoxia 1 4.17
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child who presented symptoms at birth died on the
seventh day from cytomegalovirus congenital disease,
which was confirmed by molecular diagnosis and by
laboratory and clinical tests. This newborn was pre-
term (less than 37 weeks), had low-birth weight
(below the 10th percentile of the intrauterine growth
curve), decreased head circumference with a trace of
microcephaly (below the 10th percentile of the intra-
uterine growth curve), petechiae, globular abdomen,
discomfort while breathing, generalized edema, jaun-
dice, tachypnea, sloughing, and weak reflexes. Labora-
tory examinations indicated altered C-reactive protein
levels and increased GOT.
The two children with late symptoms showed audi-
tory alterations characterized by the lack of auditory
response detected at 2 years of age, and were referred
to BERA. Previous studies have reported varying rates
of hearing loss associated with CMV congenital infec-
tion, time of clinical follow-up, and primary maternal
infection during pregnancy [7, 20].
Only 12 mothers or guardians attended the previously
scheduled post-natal follow-up visits. Some mothers dis-
continued the supervision for different reasons including
changed telephone numbers or changed addresses. The
high number of absences in follow-up visits may mask
the infection symptomatology and even prevent thoseTable 3 Clinic and epidemiological characteristics of mothers








12 to 15 years old 4 (16 %) 124 (6 %) 0.033
>5 sexual partners 20 (80 %) 1773 (85.4 %) 0.418
Sexual onset before
19 years old
24 (96 %) 1776 (85.6 %) 0.546
First child 17 (68 %) 456 (22 %) 0.011
Close contact with
children < 2 years old
10 (40 %) 1108 (53.4 %) 0.506
Other infectious
disease
0 (0.0 %) 230 (11.1 %)
Genitourinary disease 0 (0.0 %) 45 (2.2 %)
Values of p < 0.05 are considered significantchildren from receiving proper care. Furthermore, late
onset symptoms related to CMV infection may be mis-
taken for other diseases or even go unnoticed. The diffi-
culty to reach patients confirms the importance of
creating a health education program to educate the
population about these infections and the strategies to
prevent and treat them.
The maternal age and number of children were as-
sociated with CMV congenital infection. In addition,
infection was more frequent in young mothers (12 –
15 years old). The early sexual maturity and lack of
information concerning CMV infection may increase
the risk of primary infections, which lead to a higher
likelihood of vertical virus transmission as demon-
strated in the literature [21, 22]. Moreover, the
present study showed that most young mothers were
primiparous and that primiparous women had higher
likelihood of transmitting the infection vertically,
thereby contributing to the increased infection rate
among the newborns.Conclusions
The prevalence of CMV infection in Ilhéus, Brazil, was
similar to the findings of other studies conducted in
low-income regions and most infected children were
asymptomatic. However, late symptoms related to CMV
can occur, leading to progressive and irreversible sequels.
Besides, the high number of absences in follow-up visits
observed in this study may mask the infection symptom-
atology and even prevent those children from receiving
proper care. It is noteworthy that the implementation of
a national educational policy and the monitoring of in-
fected children are important strategies aimed to de-
crease the risk of virus transmission and detect late
symptoms and sequelae.
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